The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 26 | — | 20.1x | Below average | |
Growth | 48 | 32.8% | 5.6% | Near average | |
Quality | 44 | -3.7% | 7.6% | Near average | |
Safety | 83 | -6.1x | 0.4x | Above average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Hims & Hers Health, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Hims & Hers Health, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Hims & Hers Health stock saw a slight 2.2% increase in its average target price over the past week to reach $27, driven by 3 new analysts entering the coverage range. Despite this slight improvement in consensus, the Analyst Dispersion remains very wide, with the range spanning from a low of $12.5 to a high of $60, reflecting a state of extreme uncertainty regarding the company's fair valuation.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.